This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 1 EPO patent. Top assignees: Baylor College of Medicine, The United States of America, as Represented by the Secretary, Department of Health and Human Services. Active years: 2018.
Company Filing History:


Years Active: 2018
Title: The Innovations of Darayash B Tata
Introduction
Darayash B Tata is an accomplished inventor based in Silver Spring, MD (US). He holds a patent that showcases his innovative contributions to the field of pharmaceutical technology. His work focuses on the development of advanced delivery systems for therapeutic agents.
Latest Patents
Darayash B Tata's notable patent is titled "Photoactivatable lipid-based nanoparticles as vehicles for dual agent delivery." This patent describes embodiments of photoactivatable, lipid-based nanoparticles, along with methods for their creation and application. The nanoparticles are designed to include a vesicle wall that surrounds a cavity, with specific components such as 1,2-bis(tricosa-10,12-diynoyl)-sn-glycero-3-phosphocholine (DCPC) and dipalmitoylphosphatidylcholine (DPPC). Additionally, the nanoparticles incorporate 2-[1-hexyloxyethyl]-2-devinyl pyropheophorbide-a (HPPH) within the lipid bilayer, enhancing their functionality. The patent emphasizes the potential of these nanoparticles in pharmaceutical compositions.
Career Highlights
Throughout his career, Darayash B Tata has made significant contributions to the field of health and medicine. He has worked with esteemed organizations, including the Department of Health and Human Services and Baylor College of Medicine. His expertise in developing innovative delivery systems has positioned him as a key figure in pharmaceutical research.
Collaborations
Darayash B Tata has collaborated with notable professionals in his field, including Anu Puri and Robert P Blumenthal. These collaborations have further enriched his research and development efforts, leading to advancements in nanoparticle technology.
Conclusion
Darayash B Tata's work exemplifies the intersection of innovation and healthcare. His patent on photoactivatable lipid-based nanoparticles represents a significant advancement in drug delivery systems. Through his career and collaborations, he continues to contribute to the evolution of pharmaceutical technologies.